HOME | OUR COMPANY | PRODUCT PORTFOLIO | PRESS ROOM| INVESTORS | CAREERS | CONTACT US
SITE MAP | TERMS OF USE | PRIVACY POLICY

emergent biosolutions logo
Home Page
Product Portfolio Chart

Product Portfolio

Our approach is to achieve balance in the products that we develop through a portfolio comprised of innovative vaccines and therapeutics that target infectious diseases worldwide.

Infectious Disease Products & Product Candidates

BioThrax® (Anthrax Vaccine Adsorbed)

Anthrivig™ (Human Anthrax Immunoglobulin)

PreviThrax™ (Recombinant Protective Antigen Anthrax Vaccine, Purified)

Thravixa™ (Fully Human Anthrax Monoclonal Antibody)

Tuberculosis Vaccine

Typhella™ (Typhoid Vaccine Live Oral ZH9)

H5N1 Pandemic Influenza

Oncology Product Candidates

TRU-016 (Anti-CD37)

Autoimmunity Product Candidates

SBI-087 for the Treatment of Rheumatoid Arthritis (Anti-CD20)

SBI-087 for the Treatment of Systemic Lupus Erythematosus (Anti-CD20)



 

OUR COMPANY Product Portfolio Press Room INVESTORS CAREERS CONTACT US